Updates Using Technology for Better Health: Lessons from AI and Robotics for Mesothelioma Patients ByHolly Zink July 6, 2024June 14, 2024 The healthcare field is changing fast with the use of artificial intelligence (AI) and robotics, leading to better patient care.…
Treatments Using Decision Tools for Mesothelioma: Enhancing Shared Decision-Making ByHolly Zink July 3, 2024June 14, 2024 Mesothelioma, caused by asbestos exposure, is a rare and aggressive cancer. It often presents many challenges in diagnosis, treatment, and…
Diagnosis Managing Mesothelioma: Vital Tips for Older Adults and Their Caregivers ByHolly Zink July 2, 2024June 14, 2024 Mesothelioma is a rare and aggressive cancer caused by exposure to asbestos. It most often affects the lining of the…
Surgery | Treatments The Role of Surgery in Pleural Mesothelioma ByHolly Zink July 1, 2024June 14, 2024 Pleural Mesothelioma is a rare and aggressive cancer caused by asbestos exposure. The outlook for this disease is often poor,…
Diagnosis Understanding Mesothelioma Classification and Staging: Insights from the IASLC Mesothelioma Staging Project ByHolly Zink June 30, 2024May 24, 2024 Malignant pleural mesothelioma is a rare, aggressive cancer linked to asbestos. Proper classification and staging are key. They guide treatment…
Treatments Mesothelioma Prognosis and Survival Rates: Women and Extended Pleurectomy Decortication ByHolly Zink June 28, 2024May 24, 2024 Malignant pleural mesothelioma is a fast-spreading cancer tied to asbestos. Sadly, patients on standard treatments survive just 12–18 months. However,…
Treatments MARS 2 Trial: The Future of Pleurectomy Decortication in Pleural Mesothelioma ByHolly Zink June 25, 2024May 24, 2024 Malignant pleural mesothelioma, a deadly cancer, often comes from asbestos exposure. It is hard to treat due to its aggressiveness…
Treatments Leveraging the Pleural Space for Anticancer Therapies in Pleural Mesothelioma ByHolly Zink June 22, 2024May 24, 2024 Malignant pleural mesothelioma is a cancer caused by asbestos. It’s deadly and spreads quickly. It usually appears 30-50 years after…
Research Understanding Ex-Vivo Models in Mesothelioma Research ByHolly Zink June 20, 2024May 24, 2024 Malignant pleural mesothelioma is a deadly cancer caused by asbestos exposure. New cancer research gives patients and caregivers hope and…
Diagnosis Malignant Pleural Mesothelioma: Timeline and Analysis of 70 Cases ByHolly Zink June 18, 2024May 24, 2024 Malignant pleural mesothelioma is a severe cancer linked to asbestos exposure. It often appears decades after exposure. The disease’s early…